Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Croatian Medical Journal|October 29, 2002
Combination of ifosfamide, methotrexate, and etoposide (IMVP) as a salvage therapy for relapsed and refractory aggressive non-Hodgkin lymphoma: retrospective studyIgor Aurer, Nadira Duraković, Ivo Radman, et al.
Croatian Medical Journal|October 29, 2002
Surgical resection in the treatment of primary gastrointestinal non-Hodgkin's lymphoma: retrospective studyIvo Radman, Jasminka Kovacević-Metelko, Igor Aurer, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 2, 2016
Comparison of Branded and Generic Imatinib Plasma Concentrations in Patients With Chronic Myelogenous Leukemia: Unicentric StudyAlen Ostojic, Dubravka Sertic, Pavle Roncevic, et al.
Annals of Hematology|April 23, 2016
High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin's lymphomaIgor Aurer, Damir Nemet, Zdravko Mitrović, et al.
Annals of Hematology|November 20, 2020
R-CHOEP14 in younger high-risk patients with large B cell lymphoma: an effective front-line regimen with cardiac toxicity: a real-life, single-center experienceSandra Bašić-Kinda, Ivo Radman, Dino Dujmović, et al.
Medicine|June 19, 2023
Glomerular filtration rate is an independent prognostic factor in patients with B-large cell lymphomaVedran Premužić, Sandra Bašić-Kinda, Ivo Radman, et al.
Lijecnicki Vjesnik|August 9, 2005
[Rituximab in the treatment of indolent non-Hodgkin's lymphoma]Igor Aurer, Zdravko Mitrović, Ivo Radman, et al.
Croatian Medical Journal|June 20, 2015
Immunoglobulin heavy/light chain analysis enhances the detection of residual disease and monitoring of multiple myeloma patientsJosip Batinić, Zinaida Perić, Dragana Šegulja, et al.
Lijecnicki Vjesnik|June 15, 2007
[Treatment of hairy cell leukemia with cladribine]Igor Aurer, Zdravko Mitrović, Jasminka Kovacević-Metelko, et al.
Medicina (Kaunas, Lithuania)|March 28, 2024
Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP)Ida Hude Dragičević, Sandra Bašić-Kinda, Helena Markotić, et al.
Pageof 4